Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of retinol binding protein 4 polymorphism on rosiglitazone response in Chinese type 2 diabetic patients.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences - 1 Oct 2011

Zhou Fang, Huang Qiong, Dai Xingping, Yin Jiye, Wu Jing, Zhou Honghao, Gong Zhicheng, Liu Zhaoqian

Abstract excerpt

OBJECTIVE: To explore the association between rs3758539G-803A and rs10882283T-179G polymorphism of retinol binding protein 4 (RBP4) and rosiglitazone response in Chinese type 2 diabetes mellitus (T2DM) patients. METHODS: A total of 472 Chinese T2DM patients and 198 healthy subjects were enrolled to identify G-803A and T-179G genotypes using a polymerase chain reaction-restriction fragment length polymorphism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Glucose
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemic Agents

Share to Insulin

Share to Retinol-Binding Proteins, Plasma

Share to Rosiglitazone

Share to Thiazolidinediones

Share to Treatment Outcome

Source

Identifiers

PMID: 22086013
DOI: 10.3969/j.issn.1672-7347.2011.10.004

Genes

RBP4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of retinol binding protein 4 polymorphism on rosiglitazone response in Chinese type 2 diabetic patients.PMID 22086013Read ↗

Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes.Semantic proximity Read ↗

Effects of the peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser polymorphisms on rosiglitazone response in Chinese patients with type 2 diabetes mellitus.Semantic proximity Read ↗

Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients.Semantic proximity Read ↗

Impact of genetic polymorphisms of leptin and TNF-α on rosiglitazone response in Chinese patients with type 2 diabetesSemantic proximity Read ↗

Association of a SLC30A8 genetic variant with monotherapy of repaglinide and rosiglitazone effect in newly diagnosed type 2 diabetes patients in China.Semantic proximity Read ↗

Joint effects of diabetic-related genomic loci on the therapeutic efficacy of oral anti-diabetic drugs in Chinese type 2 diabetes patients.Semantic proximity Read ↗

Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population.Semantic proximity Read ↗

Adiponectin gene polymorphism rs2241766 T/G is associated with response to pioglitazone treatment in type 2 diabetic patients from southern China.Semantic proximity Read ↗

Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus.Semantic proximity Read ↗

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.Semantic proximity Read ↗

Effects of KCNQ1 polymorphisms on the therapeutic efficacy of oral antidiabetic drugs in Chinese patients with type 2 diabetes.Semantic proximity Read ↗

PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.